CR

Chandi Ram Rohil

Active Director Director DIN 02364479
DIN 02364479 First appointment Dec 2008 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2008
Shareholding value •••• Premium profile

About Chandi Ram Rohil

Data last updated:

Chandi Ram Rohil is a Director at Titanic Pharmaceuticals Private Limited (since 2008). The company operates in Trading. Titanic Pharmaceuticals Private Limited reported revenue of ₹1.38 Cr (FY 2017).

DIN 02364479
Primary Designation Director
Industry Trading
First Appointment 12 Dec 2008
Oldest Company Age 17 yrs
Largest company Titanic Pharmaceuticals Private Limited · ₹1.38 Cr (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Dec 20082008₹1.38 Cr (FY 2017)Active

Board colleagues of Chandi Ram Rohil

NameDINCompanyDesignation
Jaibir06744631Titanic Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Titanic Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chandi Ram Rohil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandi Ram Rohil

Chandi Ram Rohil currently holds 1 directorship: Titanic Pharmaceuticals Private Limited (Director, since 12 Dec 2008, revenue ₹1.38 Cr (FY 2017)).

Chandi Ram Rohil was first appointed on 12 Dec 2008 as Director at Titanic Pharmaceuticals Private Limited.

The current boards of Chandi Ram Rohil's companies include Jaibir (Titanic Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available